Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Healthcare News by GLG Council Members

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
Analysis of: U.S. looks at whether home drug stockpiles for flu pandemic makes sense (canadianpress.google.com)
There are many illnesses which people call "the flu." Not every illness with fever, aches and congestion is influenza, the only disease which these anti-virals will help.
Analysis of: Merck’s Gardasil Should Not Be Mandatory: Report (www.pharmalot.com)
Sure, it is a good idea to prevent cervical cancer and genital warts, if possible. But given the relatively low frequency of cervical cancer, and the effectiveness of regular screening, this seems like a situation where the choice should be left to the individual.
Analysis of: CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study (www.astrazeneca.com)
Jupiter study demonstrated significant reduction of cardiovascular morbidity and mortality in patients with high hs-CRP and acceptable lipid profile. This study demonstrates that rosuvastatin might play a major role in modulating inflammation pathways predisposing to cardiovascular diseases. hs-CRP is a systemic inflammation biomarker and might not be useful in  clinical practice...
Adam Fein, PhD, Founder & President
Adam Fein, PhD, Founder & President
Pembroke Consulting Inc
Analysis of: CVS joins generic drug price war (www.upi.com)
CVS Caremark (CVS) launched its new Health Savings Pass, which allows customers to buy 90 day supplies of over 400 generics for $9.99 (after paying an enrollment fee of $10). The new program sounds like a logical pre-emptive strike against anticipated share losses. Translation: an old-fashioned, race-to-the-bottom price war! A barrier has been breached with CVS’ entry into the discount retail generics...
Analysis of: CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study (www.astrazeneca.com)
20 mg of Crestor is a high dose associated in many studies with a higher incidence of side effects.  Since compliance is historically poor with any maintenance medication, it will be interesting to see if patients with normal LDL with stay compliant with this statin or any statin in the higher doses in a real world population.  It is also important to note that simvastatin, another super-statin...
David Zimmerman, PharmD, President/Owner
Doctors of Pharmacy, Inc.
Analysis of: FDA Asks if Pain Pill Is Tamper-Proof (online.wsj.com)
This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.
Donald Fleming, MD, Division Head of Hematology and Oncology
Donald Fleming, MD, Division Head of Hematology and Oncology
Davis Health System, Inc.
Analysis of: Tarceva successful as maintenance therapy (www.fiercebiotech.com)
Saturn trial attempted to focus on EGFR reative patients Saturn was positive as a maintenance therapy, while concurrent was not
James Leonard, Chief Information Officer
The Regional Medical Center at Memphis
Analysis of: Hospitals See Drop in Paying Patients (www.nytimes.com)
Significant decline scheduled procedures. Greater activity in Emergency Room combined with increase in uninsured and underinsured patients. A difficult outlook for Acute care facilities.
Carlos Dujovne, MD, Professor of Medicine and Director
Carlos Dujovne, MD, Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study (www.astrazeneca.com)
1:Crestor is the most potent statin in the market,yet is 3d in sales behind Zocor and Lipitor.2:The efficacy supriority together with its capacity to lower CRP levels led to the highest rate of ASCVD prevention in the shortest period of time evr documented in statin trials.3:The trial in near 18,000 patients with otherwise lower risk of ASCVD offered $0% reduction y many ascvd endpoints.4:There were...
Steve Rubinstein, OD, Optometrist
Steve Rubinstein, OD, Optometrist
Sound Shore Vision Care
Analysis of: Eye Infection Epidemic Traced To Reduced Antifungal Properties Of Contact Lens Solution In High Temperatures (www.medicalnewstoday.com)
A new study in Archives of Ophthalmology, November 2008 indicates that a reason for the large number of infections from Bausch & Lomb's Renu Moisture Loc solution was due to poor temperature control reducing antifungal and antimicrobial efficacy.
Previous Page : 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 Next231 to 240 of 5733
Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Become a GLG Client to speak with any expert

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Request more information







*Inquiries subject to client acceptance process


Analytics


Generated at 2009-01-09T01:00:19.547